Position in NBIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,162,757
+$600,260 QoQ
Shares Held
6,899
+74.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#379
of 768 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $7,146,264 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
71,592 | $2,482,094 | |
| 2 | ZTS |
Zoetis Inc.
|
27,063 | $1,944,747 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,899 | $1,162,757 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,106 | $599,263 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,740 | $363,871 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,338 | $259,377 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,700 | $157,000 | |
| 8 | CRON |
Cronos Group Inc.
|
29,912 | $83,155 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,162,757 | 6,899 | Shares | Defined | 2026-07-31 | |
| 2025-12-31 | $562,497 | 3,966 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $878,918 | 6,261 | Shares | Defined | 2025-11-03 | |
| No filing history on record for this holder in this stock. | ||||||